RareLab

Founded in Rome, Italy, RareLab is a communications agency that has carved out a distinctive niche in the public relations and communications landscape. Operating from its headquarters at 46 Via 24 Maggio in the heart of Rome, the agency focuses its expertise on the complex and often underserved field of rare diseases. The Italian name "RareLab" itself—a play on "rare" and "laboratory"—signals its core mission: to act as a laboratory of ideas, crafting strategic projects and services for the rare disease community and beyond.

Deep Expertise in Rare Diseases and Healthcare

RareLab’s primary specialization lies at the intersection of healthcare, patient advocacy, and public affairs. The agency demonstrates a deep understanding of the rare disease ecosystem, engaging with key stakeholders including patient associations, healthcare institutions, and policymakers. Its work frequently touches on areas such as "policy shaping malattie rare" (rare disease policy shaping), "accesso al mercato" (market access), and "sostenibilità delle cure" (sustainability of care). RareLab also monitors and contributes to legislative frameworks, as evidenced by its involvement with "OSMR Osservatorio Malattie Rare" (Rare Disease Observatory) and "OSN Screening Neonatale" (Newborn Screening Observatory). This positions the agency as a strategic partner for organizations navigating the regulatory and communication challenges of bringing therapies and awareness to rare conditions.

Integrated Services: From Awareness to Advocacy

RareLab offers a comprehensive suite of services that blend traditional PR with specialized healthcare communications. The agency’s approach is grounded in both "normative" (regulatory) and "sensibilizzazione" (awareness-raising) strategies, enabling clients to address both policy and public perception. Key service areas include:

• Strategic consulting for patient advocacy and non-profit organizations
• Event management for conferences, conventions, and training sessions on rare diseases
• Editorial and publishing services, including the management of a specialized "testata giornalistica" (sector-specific newspaper) covering rare diseases
• Social media campaigns ("campagne social") and public relations campaigns to build awareness and community engagement
• Public affairs and institutional relations to shape policies and guidelines ("linee guida")
• Research and advisory on advanced therapies and newborn screening
• Scientific and technical consulting services related to market access and healthcare communication

This mix of "consulenza" (consulting), "formazione" (training), and "editoria" (publishing) allows RareLab to support clients across the full lifecycle of a healthcare initiative—from research and policy to public communication and patient support.

A Network Approach with Institutional Reach

RareLab operates as a connector within the Italian healthcare ecosystem. The agency’s work with "istituzioni" (institutions), "non-profit" organizations, and "pubblici affari" (public affairs) suggests a client base that includes patient groups, pharmaceutical companies, research foundations, and healthcare providers. Its focus on "ricerca sulle terapie avanzate" (research on advanced therapies) and "screening neonatale" (newborn screening) indicates partnerships with scientific bodies and advocacy networks. By maintaining a dedicated news outlet and organizing events like "convegni" (conferences), RareLab creates platforms for dialogue among clinicians, regulators, and patients—a critical function in a field where information and collaboration are scarce.

RareLab is particularly well-suited for organizations operating in the rare disease space, including biotech and pharma companies seeking to launch or expand therapies in Italy, patient advocacy groups aiming to influence policy or raise awareness, and research institutions needing to communicate complex scientific advances to lay and professional audiences. Its Rome base gives it proximity to Italian government ministries and regulatory bodies, making it a natural choice for public affairs campaigns targeting national healthcare policy. For any entity looking to build credibility, foster community, or navigate the intricacies of rare disease communications in Italy, RareLab offers a focused, knowledgeable, and strategic partnership.